The Scientist

» biotherapeutics

Most Recent

image: CAR-T Therapies Get $1 Billion Boost

CAR-T Therapies Get $1 Billion Boost

By Bob Grant | July 1, 2015

The biotech firm Celgene inks a huge collaboration deal with Juno Therapeutics to develop and commercialize new cancer immunotherapies.


image: Who Owns CRISPR?

Who Owns CRISPR?

By Jenny Rood | April 3, 2015

With one US patent awarded and many other applications under consideration for the popular genome-editing technology, companies are adopting multiple strategies to navigate the complex intellectual property landscape.


image: The CAR T-Cell Race

The CAR T-Cell Race

By Vicki Brower | April 1, 2015

Tumor-targeting T-cell therapies are generating remarkable remissions in hard-to-beat cancers—and attracting millions of dollars of investment along the way.


image: The Second Coming of RNAi

The Second Coming of RNAi

By Eric Bender | September 1, 2014

Now showing clinical progress against liver diseases, the gene-silencing technique begins to fulfill some of its promises.

1 Comment

image: Virus Found in Sf9 Cell Line

Virus Found in Sf9 Cell Line

By Kerry Grens | May 22, 2014

A government lab finds a novel virus present in cell lines used for therapeutic production that were thought to be virus-free.


image: Wrestling with Recurrent Infections

Wrestling with Recurrent Infections

By Gayatri Vedantam and Glenn S. Tillotson | May 1, 2011

Clostridium difficile is evolving more robust toxicity, repeatedly attacking its victims, and driving the search for alternative therapies to fight the infection.


Popular Now

  1. Could Rapamycin Help Humans Live Longer?
  2. Renowned Physicist Stephen Hawking Dies
  3. Elena Rybak-Akimova, Chemical Kinetics Expert, Dies
  4. Pupil Response to an Optical Illusion Tied to Autistic Traits